Notice Pursuant to Section 708A(5)(e) of the Corporations Act 2001
A Cleansing Notice under Section 708A was lodged at ASX on 12 October 2021. Please click to review the full announcement at ASX.
A Cleansing Notice under Section 708A was lodged at ASX on 12 October 2021. Please click to review the full announcement at ASX.
The document “Application for quotation of +securities” was lodged at ASX on 30th September 2021. Please click to review the full announcement at ASX.
A Cleansing Notice under Section 708A was lodged with ASX on 30th September, 2021. Please click to review the full announcement at ASX.
The document “Notification of cessation of +securities” was lodged at ASX on 16 September, 2021. Please click to review the full announcement at ASX.
The document “Application for quotation of +securities” was lodged with ASX on 16 September, 2021. Please click to review the full announcement at ASX.
Further to the announcement made on 13th August 2021, Imagion Biosystems Limited provides this supplementary announcement in relation to the agreement with Global Cancer Technology
The document “Notice Pursuant to Section 708A(5)(e) of the Corporations Act 2001” was lodged with ASX on 16 September 2021. Please click to review the
Imagion Biosystems is pleased to provide its investors with its September 2021 Investor Newsletter. The newsletter details recent new company developments and activities, including: Message
The document “Application for quotation of +securities” was lodged with ASX on 9 September, 2021. Please click to review the full announcement at ASX.
The document “Notice Pursuant to Section 708A(5)(e) of the Corporations Act 2001” was lodged with ASX on 9 September 2021. Please click to review the
Stay informed about our latest news and developments.
© Imagion Biosystems, Ltd. All Rights Reserved | Privacy Policy | Terms & Conditions | Careers | Corporate Governance
We have temporarily suspended our nanoparticle operations. Please revisit us in the future. We apologize for the inconvenience. Any questions, please email: info@imagionbio.com Dismiss